James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 10,000 shares at $75.13 ($751K) on 2023-02-23, disclosed to the SEC on 2023-02-27.
Open-market sale of $751k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2024-05-03 | $3.0M | — | Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |